# Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies

> **NCT04030572** · EARLY_PHASE1 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 3 (actual)

## Conditions studied

- Neuro-Degenerative Disease
- Cancer

## Interventions

- **DRUG:** Clonidine Pill

## Key facts

- **NCT ID:** NCT04030572
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-10
- **Primary completion:** 2020-03-17
- **Final completion:** 2020-03-17
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Not logistically feasible during the COVID pandemic
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04030572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04030572, "Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04030572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*